TBT exposure poses a high risk for the development of type 2 diabetes mellitus in mice because it produces insulin resistance, alters hepatic glucose metabolism, increases insulin levels, and decreases serum glucagon levels. The gene discussed is INS; the disease is diabetes mellitus.